IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 53.23 USD Market Closed
Market Cap: 674.4m USD
Have any thoughts about
IRadimed Corp?
Write Note

IRadimed Corp
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRadimed Corp
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
IRadimed Corp
NASDAQ:IRMD
Total Receivables
$10.4m
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
24%
Becton Dickinson and Co
NYSE:BDX
Total Receivables
$3B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
10%
Boston Scientific Corp
NYSE:BSX
Total Receivables
$2.5B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Total Receivables
$3.7B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Receivables
$6.9B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Receivables
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
13%
CAGR 10-Years
16%
No Stocks Found

IRadimed Corp
Glance View

Market Cap
674.4m USD
Industry
Health Care

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

IRMD Intrinsic Value
41.01 USD
Overvaluation 23%
Intrinsic Value
Price

See Also

What is IRadimed Corp's Total Receivables?
Total Receivables
10.4m USD

Based on the financial report for Sep 30, 2024, IRadimed Corp's Total Receivables amounts to 10.4m USD.

What is IRadimed Corp's Total Receivables growth rate?
Total Receivables CAGR 10Y
24%

Over the last year, the Total Receivables growth was -19%. The average annual Total Receivables growth rates for IRadimed Corp have been 13% over the past three years , 5% over the past five years , and 24% over the past ten years .

Back to Top